AI-generated analysis. Always verify with the original filing.
On February 9, 2026, Cue Biopharma, Inc. appointed Lucinda Warren, its current Chief Business Officer, as Chief Financial and Business Officer. Ms. Warren assumed the duties of principal financial officer and principal accounting officer effective immediately, with no additional compensation granted for the new roles.
Event Type
Disclosure
Mandatory
Variant
8-K
. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February
Lucinda Warren
Effective: 2026-02-09
Board of Directors appointment